Explore how integrative multi-omics drug sensitivity data can improve your drug development.
Webinar
Emerging Treatment Approaches of High-Risk Myelodysplastic Syndrome
The Stanford University Cancer Center and the MDS Foundation are proud to bring you this complimentary webinar presented by Stanford’s Dr. Michael Spinner, post-doctoral medical fellow, oncology, and moderated by the MDS Foundation’s Sandra Kurtin, Ph.D., ANP-C, AOCN.